Calliditas Current ratio
2.9
Last period Current ratio
-86%
Current ratio has decreased in 5 years
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Calliditas Therapeutics
Company Analysis
CALTX.ST valuation, rating, competitors, insights and company profile
Eyestock Rating
CALTX.ST financial analysis by Eyestock methodology
Valuation
CALTX.ST valuation using historical relative method
Financials
CALTX.ST revenue, earnings, ROE, ROIC and other financials
Statements
CALTX.ST Income Statements, Balance Sheet and Cash Flow Statements
Dividends
CALTX.ST dividend yield and annual dividend
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
What is Current ratio of Calliditas Therapeutics ?
Calliditas Therapeutics`s Current ratio for the last twelve months ended 2024-06-30 is 2.9